Robert A. Beckman

5.5k citations

113 papers · 3.7k indexed · h-index 33

Impact in

Statistics and Probability top 1%
- Statistical Methods in Clinical Trials
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Statistics and Probability 28
- Statistical Methods in Clinical Trials 28
Cancer Research 28
- Cancer Genomics and Diagnostics 27

Co-authors: Lawrence A. Loeb James R. HeathCong ChenHugh M. Davis Louis M. Weiner Albert S. Mildvan Sophia N. Yaliraki Mauricio Barahona
Journals: Journal of Clinical Oncology (8 papers)Statistics in Biopharmaceutical Research (8 papers)Clinical Cancer Research (5 papers)Journal of Biological Chemistry (3 papers)Statistical Methods in Medical Research (3 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Robert A. Beckman

111 papers receiving 3.6k citations

Peers

Countries citing papers authored by Robert A. Beckman

Since Specialization

Citations

This map shows the geographic impact of Robert A. Beckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Beckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Beckman more than expected).

Fields of papers citing papers by Robert A. Beckman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Beckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Beckman. The network helps show where Robert A. Beckman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert A. Beckman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Beckman Line = papers co-authored together Robert A. Beckman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Integrating Sustainability Pillars Into Trial Design Decision‐Making: Results of an International Survey Clinical and Translational Science ·Pritibha Singh, Oleksandr Sverdlov, Robert A. Beckman, Andrea M. Burden	2025	1
2	Generalized Evolutionary Classifier for Evolutionary Guided Precision Medicine JCO Precision Oncology ·Matthew McCoy, Chen‐Hsiang Yeang, Ana L.P. dos Santos, Stanley Tam, Rebecca B. Riggins, Deepak Parashar, Robert A. Beckman	2025	1
3	Neutral evolution of rare cancer mutations in the computer and the clinic npj Systems Biology and Applications ·Robert A. Beckman	2024	1
4	Tumor-Agnostic Approvals: Insights and Practical Considerations Clinical Cancer Research ·Regina Coeli Vasques de Miranda Burneiko, Robert A. Beckman, Xiaoyun Li, Weidong Zhang, Stanislav Michal, Maysam Alameddine, Linda Sun, Hong Tian, Jingjing Ye, VS Kennedy, Hongxia Ren	2023	4
5	Design and Execution of Sustainable Decentralized Clinical Trials Clinical Pharmacology & Therapeutics ·Pritibha Singh, Andrea M. Burden, Fanni Natanegara, Robert A. Beckman	2023	9
6	Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer Endocrinology ·Ana L.P. dos Santos, Donald Aten, Lü Jin, Stanley Tam, A. BRUNY, Manasi Balachandran, Mircea Podar, Matthew McCoy, Robert A. Beckman, Rebecca B. Riggins	2023	5
7	Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective Orphanet Journal of Rare Diseases ·Mercedeh Ghadessi, Junrui Di, Chenkun Wang, Kiichiro Toyoizumi, Seung Yong Kim, Chaoqun Mei, Charmaine Demanuele, Rui Tang, Maria Pulido Hernández, Robert A. Beckman	2023	22
8	Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival Cancer Research Communications ·Jason Roszik, J. Jack Lee, Yu‐Hung Wu, Xi Liu, Masanori Kawakami, Jonathan M. Kurie, Anas Belouali, Simina M. Boca, Samir Gupta, Robert A. Beckman, Subha Madhavan, Ethan Dmitrovsky	2022	3
9	A roadmap to using randomization in clinical trials BMC Medical Research Methodology ·Vance W. Berger, Qi Tang, Mongera Nicola, Jonathan Chipman, Colin Everett, N Heussen, Catherine Hewitt, R.-D Hilgers, Siti Nurafifah, Nettov Cg, 陈健佳, Oleksandr Sverdlov, Diane Uschner, Robert A. Beckman, (unknown)	2021	60
10	Evidence-Based Network Approach to Recommending Targeted Cancer Therapies JCO Clinical Cancer Informatics ·Jayaram Kancherla, Shruti Rao, Krithika Bhuvaneshwar, Rebecca B. Riggins, Robert A. Beckman, Subha Madhavan, Héctor Corrada Bravo, Simina M. Boca	2020	7
11	A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG) Orphanet Journal of Rare Diseases ·Mercedeh Ghadessi, Rui Tang, Joey Tianyi Zhou, Rong Liu, Chenkun Wang, Kiichiro Toyoizumi, Chaoqun Mei, Lixia Zhang, C. Q. Deng, Robert A. Beckman	2020	99
12	Extensive subclonal mutational diversity in human colorectal cancer and its significance Proceedings of the National Academy of Sciences ·Lawrence A. Loeb, Brendan F. Kohrn, Jawad Afzal, G. Shanmugavel, Eun Hyun Ahn, Jacintha O’Sullivan, Jesse J. Salk, Mary P. Bronner, Robert A. Beckman	2019	37
13	Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study Clinical Cancer Research ·Magnus T. Dillon, Lorna Grove, Kate Newbold, Heather M. Shaw, Nicholas F. Brown, Jeanne Mendell, Shuquan Chen, Robert A. Beckman, Anne Jennings, Marivic Ricamara, Jonathan Greenberg, Martin Förster, Kevin J. Harrington	2018	14
14	Long range personalized cancer treatment strategies incorporating evolutionary dynamics Biology Direct ·Chen-Hsiang Yeang, Robert A. Beckman	2016	14
15	Efficient, Adaptive Clinical Validation of Predictive Biomarkers in Cancer Therapeutic Development Advances in experimental medicine and biology ·Robert A. Beckman, Cong Chen	2015	9
16	Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors Clinical Cancer Research ·Patricia LoRusso, Pasi A. Jänne, Moacyr Oliveira, Naiyer A. Rizvi, Lisa Malburg, Vicki L. Keedy, Lorrin Yee, Catherine Copigneaux, Thore Hettmann, Chi‐Yuan Wu, Agnes Ang, Abdel‐Baset Halim, Robert A. Beckman, Darrin M. Beaupre, Jordan Berlin	2013	74
17	Molecular Imaging of Death Receptor 5 Occupancy and Saturation Kinetics In Vivo by Humanized Monoclonal Antibody CS-1008 Clinical Cancer Research ·Ingrid J.G. Burvenich, Shouming Li, Glenn A. Cartwright, Graeme O’Keefe, Eliza Fishman, Diana Cao, Sylvia Gong, Anderly C. Chüeh, John M. Mariadason, Martin W. Brechbiel, Robert A. Beckman, Kôsaku Fujiwara, Reinhard von Roemeling, Andrew M. Scott	2013	13
18	Readiness, Behavior, and Foundational Mathematics Course Success Journal of developmental education ·Ivana Zovko, Ayyappan Muthuvel, T Doulatabadi, Robert A. Beckman, Alex Casillas, Clyden Harris, Jeff Allen, Mary Ann Hanson, Miriam Bahamonde Blanco, Steve Robbins	2013	3
19	A phase 1 study of efatutazone, an oral peroxisome proliferator‐activated receptor gamma agonist, administered to patients with advanced malignancies Cancer ·Michael J. Pishvaian, John L. Marshall, Andrew J. Wagner, Jimmy Hwang, Shakun Malik, Ion Cotarla, John F. Deeken, Aiwu Ruth He, Jeremiah Laanoi, Abdel‐Baset Halim, Hamim Zahir, Catherine Copigneaux, Kejian Liu, Robert A. Beckman, George D. Demetri	2012	60
20	Guidelines for the Use of Oversampling in Protein NMR Journal of Magnetic Resonance Series A ·Robert A. Beckman, Erik R. P. Zuiderweg	1995	15

About Robert A. Beckman

Robert A. Beckman is a scholar working on Statistics and Probability, Cancer Research, Modeling and Simulation, Oncology and Economics and Econometrics, having authored 113 papers that have together received 3.7k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (28 papers), Cancer Genomics and Diagnostics (27 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers), HER2/EGFR in Cancer Research (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Evolution and Genetic Dynamics (8 papers). The work is most often cited by research in Statistics and Probability (371 citations), Cancer Research (662 citations), Oncology (787 citations), Molecular Biology (1.8k citations) and Modeling and Simulation (112 citations). Robert A. Beckman has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Lawrence A. Loeb, James R. Heath, Cong Chen, Hugh M. Davis, Louis M. Weiner, Albert S. Mildvan, Sophia N. Yaliraki, Mauricio Barahona, Michael Diehl and Jason H. Bielas. Their work appears in journals such as Journal of Clinical Oncology, Statistics in Biopharmaceutical Research, Clinical Cancer Research, Journal of Biological Chemistry and Statistical Methods in Medical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact